<?xml version="1.0" encoding="UTF-8"?>
<ref id="R40">
 <label>[40]</label>
 <mixed-citation publication-type="book">
  <comment>Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds. UMIN Clinical Trials Registry identifier: UMIN000024312. Updated May 25, 2017. 
   <ext-link ext-link-type="uri" xlink:href="https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027997" xmlns:xlink="http://www.w3.org/1999/xlink">https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027997</ext-link>.
  </comment>
 </mixed-citation>
</ref>
